LONDON & SEATTLE--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the aging eye, today ...

LONDON & SEATTLE, January 29, 2026--(BUSINESS WIRE)--Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to rejuvenate vision in the ...

You get what you pay for with gaming laptops, and at this cost level you can expect a few things to be less than premium. With its older CPU and low-end GPU, the Acer Nitro V15 still manages to pump ...

The gradual loss of near vision that is a natural part of aging can be addressed by glasses, contact lenses, or even surgical procedures. A presbyopia eye drop developed by Tenpoint Therapeutics now ...

The Food and Drug Administration on Wednesday approved Yuvezzi, an eye drop Tenpoint Therapeutics developed for presbyopia. The transatlantic biotechnology company also announced it raised $235 ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The company, whose U.S ...

U.S. FDA Approves YUVEZZI as the only dual-agent, once daily presbyopia-correcting eye drop Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking ...

Tenpoint Therapeutics, Ltd., a global, commercial biotechnology company focused on developing groundbreaking treatments to improve vision in the aging eye, today announced that the U.S. Food and Drug ...

YUVEZZI (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% is the only dual-agent presbyopia-correcting eye drop intentionally designed to deliver durability, tolerability, and safety ...

Retail sales were up 0.6% month-over-month in November and were 3.3% higher than a year ago, according to the U.S. Census Bureau. The retail sales growth was higher than the 0.4% increase economists ...